Allogene Therapeutics
ALLO
#7148
Rank
โ‚น33.36 B
Marketcap
โ‚น159.11
Share price
1.63%
Change (1 day)
-37.48%
Change (1 year)

Allogene Therapeutics (ALLO) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น24.80 Billion

According to Allogene Therapeutics 's latest financial reports the company has โ‚น24.80 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Allogene Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น42.80 B25.77%
2021-12-31โ‚น34.03 B-43.78%
2020-12-31โ‚น60.54 B60.04%
2019-12-31โ‚น37.83 B17.78%
2018-12-31โ‚น32.12 B
2017-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น23.17 B-6.58%๐Ÿ‡บ๐Ÿ‡ธ USA